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Brief Definitive Report

RAG-induced DNA double-strand breaks
signal through Pim2 to promote pre–B cell
survival and limit proliferation
Jeffrey J. Bednarski,1 Andrew Nickless,1 Deepta Bhattacharya,2
Rupesh H. Amin,3 Mark S. Schlissel,4 and Barry P. Sleckman2
of Pediatrics and 2Department of Pathology and Immunology, Washington University School of Medicine,
St. Louis, MO 63110
3Fred Hutchinson Cancer Research Center, Basic Sciences Division, Seattle, WA 98109
4Department of Molecular and Cellular Biology, University of California, Berkeley, Berkeley, CA 94720

Interleukin 7 (IL-7) promotes pre–B cell survival and proliferation by activating the Pim1 and
Akt kinases. These signals must be attenuated to induce G1 cell cycle arrest and expression of
the RAG endonuclease, which are both required for IgL chain gene rearrangement. As lost
IL-7 signals would limit pre–B cell survival, how cells survive during IgL chain gene rearrangement remains unclear. We show that RAG-induced DNA double-strand breaks (DSBs) generated during IgL chain gene assembly paradoxically promote pre–B cell survival. This occurs
through the ATM-dependent induction of Pim2 kinase expression. Similar to Pim1, Pim2
phosphorylates BAD, which antagonizes the pro-apoptotic function of BAX. However, unlike
IL-7 induction of Pim1, RAG DSB-mediated induction of Pim2 does not drive proliferation.
Rather, Pim2 has antiproliferative functions that prevent the transit of pre–B cells harboring
RAG DSBs from G1 into S phase, where these DNA breaks could be aberrantly repaired. Thus,
signals from IL-7 and RAG DSBs activate distinct Pim kinase family members that have
context-dependent activities in regulating pre–B cell proliferation and survival.
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Sleckman@
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Abbreviations used: BCR,
B cell receptor; DSB, doublestrand break; NHEJ, non
homologous end joining;
shRNA, short hairpin RNA.

B cell development relies on coordinate signals
from cell surface antigen and cytokine receptors. IgH chain antigen receptor genes are
assembled in pro–B cells and pair with the
surrogate light chain (5 and VpreB) to form
the pre–B cell receptor (BCR) (Herzog et al.,
2009). Signals from the pre-BCR drive cellular
expansion, transit from the pro–B to pre–B cell
stage, and initiation of IgL chain gene assembly
(Herzog et al., 2009). At the pre–B cell stage,
successful assembly of an IgL chain gene and
subsequent pairing with the IgH chain leads to
the expression of a BCR, which signals termination of antigen receptor gene assembly and
promotes transition to the immature B cell stage
(Bassing et al., 2002; Herzog et al., 2009).
Antigen receptor genes are assembled through
V(D)J recombination, a reaction initiated by the
RAG1 and RAG2 proteins, which together form
the RAG endonuclease (Fugmann et al., 2000).
V(D)J recombination is restricted in developing
lymphocytes to the G1 phase of the cell cycle, in
part as a result of the degradation of RAG2 in
S phase (Desiderio et al., 1996). RAG introduces
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DNA double-strand breaks (DSBs) at the border
of two recombining gene segments (V, D, or J)
and their flanking RAG recognition sequences,
termed recombination signals (Fugmann et al.,
2000). RAG DNA cleavage forms two blunt signal ends and two hairpin-sealed coding ends.
These DNA ends are processed and joined by
the nonhomologous end-joining (NHEJ) pathway of DNA repair to form a signal joint and a
coding joint, which completes formation of the
second exon of antigen receptor genes (Rooney
et al., 2004). The DNA breaks generated during
this process activate the ATM kinase, which promotes canonical DNA damage responses, including cell death pathways which ultimately kill cells
with persistent unrepaired RAG DSBs (Gapud
and Sleckman, 2011).
In addition to pre-BCR and BCR signals,
IL-7 receptor signals are important to promote
© 2012 Bednarski et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after
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Figure 1. Akt and Pim1 promote IL-7-dependent survival. (A) Cell
death assessed by 7AAD uptake in wild-type pre–B cells cultured in IL-7
(+IL-7) and 48 h after IL-7 withdrawal (IL-7). (B) Western blot analysis of
Pim1, phosphorylated Foxo1 (p-Foxo1), phosphorylated Akt (p-Akt), and
total Akt in whole cell lysates from wild-type pre–B cells in IL-7 (+) and 48 h
after IL-7 withdrawal (). Gapdh is shown as a protein loading control.
Numbers represent band intensity relative to +IL-7 and standardized to
loading controls. (C) Cell death assessed by 7AAD uptake in wild-type
(Pim1+/+) and Pim1/ pre–B cells cultured for 48 h in media containing
IL-7 and 5 µM Akt inhibitor VIII (+) or DMSO () for 48 h. Shown is the
mean and standard deviation from three independent experiments. Data in
A and B are representative of at least three independent experiments.

induction of Pim1, Pim2 has distinct context-dependent survival and proliferative activities in cells undergoing V(D)J
recombination. Our findings establish that signals from RAG
DSBs are coordinated with those from the IL-7 receptor to regulate the survival and proliferation of developing pre–B cells.
RESULTS AND DISCUSSION
Pim1 and Akt provide survival signals in response to IL-7
Large proliferating pre–B cells require the continuous presence of
IL-7 (Fig. 1 A; Milne and Paige, 2006). IL-7 induces expression
of the Pim1 kinase, which promotes survival as indicated by the
enhanced uptake of 7AAD in Pim1/ pre–B cells compared
with wild-type (Pim1+/+) pre–B cells in the presence of IL-7
Rag-induced DNA breaks drive pre–B cell survival | Bednarski et al.
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survival and proliferation of developing B cells (Milne and Paige,
2006). The IL-7 receptor activates the JAK–STAT (STAT5)
pathway, which induces the expression of Pim1 (Goetz et al.,
2004). Pim1 is a member of a family of constitutively active
serine-threonine kinases, which also includes Pim2 and Pim3, and
supports lymphocyte proliferation and survival (Amaravadi and
Thompson, 2005; Nawijn et al., 2011). The importance of IL-7
receptor signals is indicated by the block in B cell development
observed in mice deficient for IL-7, IL-7 receptor, or STAT5
(Malin et al., 2010b; Milne and Paige, 2006). Pim1-deficient
mice exhibit defects in B cell development, albeit to a lesser
extent than mice compromised for IL-7 signaling (Domen
et al., 1993). The incomplete developmental block in Pim1/
mice suggests that other signaling pathways can contribute to
pre–B cell proliferation and survival. In this regard, in developing T cells, IL-7 activates both Pim1 and the Akt kinase to
support cell survival (Li et al., 2004). Whether Akt has a similar
prosurvival function in developing B cells is not known.
Although IL-7 signals are critical for developing pre–B cells,
these signals must be attenuated during IgL chain gene
assembly as: (1) IL-7 signals suppress RAG gene expression in
pre–B cells, (2) proliferative signals from IL-7 promote the
degradation of RAG2 as cells pass into S phase, (3) persistent
proliferative signals promote genomic instability by transiting
cells with RAG DSBs into S phase before these DNA breaks can
be repaired by NHEJ, and (4) IL-7 signals negatively regulate IgL
gene accessibility (Billips et al., 1995; Desiderio et al., 1996; Amin
and Schlissel, 2008; Johnson et al., 2008; Malin et al., 2010a).
Recent studies have suggested that IL-7 signaling in pre–B cells
may be attenuated through the pre-BCR–mediated expression
of CXCR4, which may promote migration of pre–B cells
away from IL-7–producing stromal cells in the bone marrow
(Tokoyoda et al., 2004; Johnson et al., 2008).
Despite the importance of attenuating IL-7 proliferative sig
nals, lost IL-7 survival signals could limit the time for pre–B cells
to assemble a functional IgL chain gene. IgL gene assembly
occurs through the rearrangement of a V gene segment to
one of four J gene segments. The structure of the locus is such
that multiple V to J rearrangements can, and often do, occur
on a single allele. A single rearrangement can take several hours
to complete and, thus, pre–B cells may have to survive for an
extended period of time as they iteratively assemble IgL genes
in an attempt to express a functional IgL chain (Casellas et al.,
2001). Moreover, cells that fail to generate an IgL chain gene
often go on to attempt IgL chain gene assembly (Arakawa
et al., 1996). What promotes the survival of pre–B cells that are
assembling IgL chain genes is largely unknown.
In response to RAG DSBs, the activation of ATM induces
a broadly functional genetic program (Bredemeyer et al., 2008).
In this paper, we develop an experimental approach designed to
elucidate the function of signaling pathways activated by RAG
DSBs in the regulation of B cell development. We find that
RAG DNA breaks generated during IgL chain gene rearrangement promote the survival of pre–B cells that have lost IL-7 signals. This cytokine-independent survival requires the induction
of Pim2 expression by RAG DSBs. When compared with IL-7
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(Fig. 1, B and C; Domen et al., 1993). However, survival is not
completely abrogated in Pim1/ pre–B cells, suggesting that
IL-7 regulates additional prosurvival pathways. In this regard, the
Akt kinase is activated in pre–B cells by IL-7 as indicated by its
autophosphorylation and the phosphorylation of Foxo-1, a
known target of Akt in pre–B cells (Fig. 1 B; Amin and Schlissel,
2008). Inhibition of Akt kinase activity with Akt inhibitor VIII
leads to an increase in pre–B cell death in the presence of IL-7
(Fig. 1 C). Additionally, treatment of Pim1/ pre–B cells with
this inhibitor leads to a synergistic increase in cell death (Fig. 1 C).
Together, these findings demonstrate that Pim1 and Akt function
to regulate pre–B cell survival in response to IL-7.
RAG DSBs activate DNA damage responses in pre–B cells
To elucidate the signaling pathways downstream of RAG
DSBs in pre–B cells, we generated mice that carry IgH and
Bcl2 transgenes and are deficient in RAG1 or the NHEJ
factor Artemis (RAG1/:IgH:Bcl2 and Artemis/:IgH:Bcl2
mice, respectively; Fig. S1). Artemis is a nuclease that is
required to open hairpin sealed coding ends (Rooney et al.,
2004). Thus, cells deficient in Artemis cannot make coding
joints and mice deficient in Artemis have a block in B cell
development at the pro–B cell stage as a result of their inability to generate a functional IgH chain gene (Rooney et al.,
2004). Mice deficient in RAG1 cannot generate RAG DSBs
and thus also exhibit a block at the pro–B cell stage (Fugmann
et al., 2000). However, the inclusion of an IgH transgene
in RAG1/:IgH:Bcl2 and Artemis/:IgH:Bcl2 mice allows
for pre-BCR expression and transit from the pro–B cell
(B220+CD43+) to the pre–B cell stage (B220+CD43) where
JEM Vol. 209, No. 1

further development is blocked as a result of the inability to
generate a functional IgL chain gene (Fig. S1; Bassing et al.,
2002; Herzog et al., 2009).
Southern blot analysis of genomic DNA from Artemis/:
IgH:Bcl2 pre–B cells cultured in IL-7 reveals low levels of
unrepaired J coding ends generated by RAG cleavage because IL-7 suppresses, but does not abrogate, V(D)J recombination (Fig. 2 A; Milne et al., 2004). IL-7 withdrawal enhances
RAG expression, leading to increased generation of J coding
ends in Artemis/:IgH:Bcl2 pre–B cells (Fig. 2 A). These
DNA DSBs lead to the phosphorylation of p53 (Fig. 2, B
and C). p53 phosphorylation was not observed in RAG1/:
IgH:Bcl2 pre–B cells or in Artemis/:IgH:Bcl2 pre–B cells
treated with the ATM inhibitor KU55933 (Fig. 2, B and C).
Thus, RAG DSBs activate ATM and downstream DNA
damage responses in pre–B cells.
Pre–B cells with RAG DSBs exhibit enhanced survival
Phosphorylation of the proapoptotic transcription factor p53
in response to RAG DSBs should promote cell death in
Artemis-deficient compared with Rag-deficient pre–B cells.
To determine the effect of RAG DSBs on pre–B cell survival, we generated RAG- and Artemis-deficient mice that
did not contain the Bcl2 transgene (Rag1/:IgH and Artemis/:IgH mice, respectively). Surprisingly, Artemis/:IgH
pre–B cells exhibited increased viability compared with
RAG1/:IgH pre–B cells at early time points (24 h) after
withdrawal of IL-7 (Fig. 2 D). Moreover, Artemis/:IgH
pre–B cells have increased survival in IL-7 (0 h), where RAG
DSBs are also generated and p53 is phosphorylated (Fig. 2).
13
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Figure 2. RAG DSBs support pre–B cell
survival. (A) A schematic of the germline (GL)
IgL locus and unrepaired J1 and J2 coding
ends (CEs) are shown. V and J gene segments
(rectangles) and their associated recombination
sequences (triangles) are shown as are the relative positions of the EcoRI and SacI sites and the
JIII probe used for Southern blot analyses.
Southern blot analysis of genomic DNA from
RAG1/:IgH:Bcl2, and Artemis/:IgH:Bcl2
pre–B cells cultured in IL-7 (0 h) and after IL-7
withdrawal (wd, 48 h). Hybridizing bands
generated by the GL IgL locus and J1 and J2
un-repaired CEs are indicated. (B) Western blot
analysis of phosphorylated p53 (p-p53) after
withdrawal of IL-7 for the indicated times.
Gapdh is shown as a protein loading control.
Numbers represent band intensity relative to
Artemis/:IgH:Bcl2 at time 0 h and standardized to loading controls. No quantitation is presented for RAG1/:IgH:Bcl2 as no bands are
present. (C) Western blot analysis of p-p53 after
IL-7 withdrawal in Artemis/:IgH:Bcl2 treated
with vehicle (DMSO) or the ATM inhibitor
KU55933. Gapdh is shown as protein loading control. Numbers represent band intensity relative to time 0 h and standardized to loading controls. (D) Viability
assessed by 7AAD uptake after withdrawal of IL-7 for the indicated times. Shown is the mean and standard deviation for three replicates. **, P < 0.0001; *, P =
0.001. Data in A, B, and D are representative examples of at least three independent experiments. Data in C are representative of two independent experiments.
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Figure 3. Pim2 induction by RAG DSBs promotes pre–B cell survival. (A) Western blot analysis of p-Akt and Pim1 in Artemis/:IgH:Bcl2 pre–B cells
after withdrawal of IL-7 for indicated times. Gapdh is shown as a protein loading control. Numbers represent band intensity relative to time 0 h and
standardized to loading controls. (B and C) Western blot analysis of Pim2 expression at indicated times after IL-7 withdrawal. Arrows indicate the three
Pim2 isoforms and the asterisk indicates a nonspecific band. Gapdh is shown as a protein loading control. Numbers represent band intensity relative to
RAG1/:IgH:Bcl2 (B) or Artemis/:IgH:Bcl2 (C) at time 0 h and standardized to loading controls. (D) Cell death assessed by 7AAD uptake 24 h after withdrawal of IL-7 from Artemis/:IgH and Artemis/:Pim2/:IgH pre–B cells. Shown is the mean and standard deviation for three replicates. (E) Artemis/:IgH pre–B cells were transduced with retroviral vector (red peaks) expressing hCD2 and shEGFP (control) or hCD2 and shPim2 then subsequently
withdrawn from IL-7 as mixed co-cultures with nontransduced cells (white peaks). Histograms demonstrate percentage of transduced cells (hCD2+, red
peak) before (+IL-7) and 72 h after (IL-7) withdrawal of IL-7. The experiment was conducted in duplicate with P = 0.008 for shPim2 compared with
shEGFP at 72 h. (F) RAG1/:IgH pre–B cells were transduced with empty retroviral vector (empty), retrovirus-expressing Pim2 (Pim2), or retrovirusexpressing kinase-dead version of Pim2 (Pim2-KD). IL-7 was withdrawn from mixed cultures of transduced and nontransduced cells. Retrovirally transduced
cells were followed by Thy1.1 expression. Data represents the fold increase in the percentage of retrovirally transduced cells at 72 h after IL-7 withdrawal
relative to the percentage in the presence of IL-7. Shown is the mean and standard deviation for duplicate cultures. (G) BAX mRNA expression assessed by
RT-PCR in cells cultured in IL-7 (+) and 48 h after () IL-7 withdrawal. Shown is the mean and standard deviation for three replicates. (H) BAX mRNA
expression assessed by RT-PCR at indicated times after IL-7 withdrawal. Shown is the mean and standard deviation for three replicates. (I) PUMA and
NOXA mRNA expression assessed by RT-PCR in cells cultured in IL-7 (+) and 72 h after () IL-7 withdrawal. Shown is the mean and standard deviation
for three replicates. (J) Western blot analysis of p-p53 after withdrawal from IL-7 for the indicated times. Gapdh is shown as a protein loading control.
Numbers represent band intensity relative to time 0 h for each genotype and standardized to loading controls. (K) Western blot analysis of phosphorylated
14
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These data demonstrate that RAG DSBs activate prosurvival
pathways that may antagonize the proapoptotic effects of
p53 in pre–B cells.
Pim2 promotes survival downstream of RAG DSBs
Upon withdrawal of IL-7, pre–B cells lose Pim1 and Akt survival signals leading to cell death (Fig. 1). However, early after
the initiation of V(D)J recombination, pre–B cells exhibit enhanced survival suggesting that RAG DNA breaks may generate compensatory survival signals (Fig. 2 D). In contrast to IL-7
signals, RAG DSBs do not activate Akt or induce Pim1 expression (Fig. 3 A). Rather, these DNA breaks induce Pim2 kinase
expression as indicated by Western blot analysis of Artemis/:
IgH:Bcl2 and RAG1/:IgH:Bcl2 pre–B cells in the presence or
absence of IL-7 (Fig. 3 B). RAG DSBs in pre–B cells with a
compound deficiency in Artemis and ATM (Artemis/:
ATM/:IgH:Bcl2) do not induce Pim2 expression (Fig. 3 C).
Thus, whereas Pim1 and Akt activities are down-regulated
upon IL-7 withdrawal, Pim2 expression is induced after ATM
activation by RAG DSBs during IgL chain gene assembly.
To determine whether Pim2 promotes pre–B cell survival,
we analyzed the response to RAG DSBs in pre–B cells deficient
in both Artemis and Pim2 (Artemis/:Pim2/:IgH). After
withdrawal of IL-7, Artemis/:Pim2/:IgH pre–B cells exhibit
increased cell death compared with Artemis/:IgH pre–B cells
(Fig. 3 D). Similarly, knockdown of Pim2 in Artemis/:IgH

pre–B cells leads to decreased viability, as indicated by a more significant loss of Artemis/:
IgH pre–B cells expressing a Pim2 short hairpin RNA (shRNA)
compared with those expressing a control shRNA after IL-7
withdrawal (Fig. 3 E, human CD2-expressing cells). Furthermore, RAG1/:IgH pre–B cells transduced with a retrovirus
expressing Pim2 exhibit enhanced survival after withdrawal of
IL-7 compared with cells expressing the empty vector (Fig. 3 F).
Expression of a kinase-deficient mutant of Pim2 (Pim2-KD) in
RAG1/:IgH pre–B cells had no effect on survival after withdrawal of IL-7 (Fig. 3 F; Fox et al., 2003). Together, these findings demonstrate that RAG DSBs promote the expression of
Pim2 and that Pim2 kinase activity augments the survival of
pre–B cells undergoing IgL chain gene assembly. Consistent
with this notion, Pim2/ mice have reduced numbers of IgLexpressing B cells (Derudder et al., 2009).
Pim2 phosphorylates Bad in response to RAG DSBs
In pre–B cells, p53 is phosphorylated by ATM in response to
RAG DSBs (Fig. 2, B and C). Upon IL-7 withdrawal, expression of the proapoptotic BAX gene, a target of p53, is upregulated by ATM in response to RAG DSBs (Fig. 3, G and H;
Vousden and Prives, 2009). The proapoptotic genes NOXA
and PUMA, which function by promoting BAX activity, also
exhibited increased expression upon IL-7 withdrawal (Fig. 3 I;
Youle and Strasser, 2008). However, this increase was similar
in Artemis/:IgH pre–B cells and RAG1/:IgH pre–B cells,
demonstrating that it is not caused by RAG DSBs (Fig. 3 I).

Bad (p-Bad) 96 h after IL-7 withdrawal. Gapdh is shown as a protein loading control. Numbers represent band intensity relative to RAG1/:IgH:Bcl2 and
standardized to loading controls. All data are representative of at least three experiments.
JEM Vol. 209, No. 1
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Figure 4. Pim2 attenuates IL-7-driven proliferation
in cells with RAG DSBs. (A) RAG1/:IgH:Bcl2, Artemis/:IgH:Bcl2, and Artemis/:Pim2/:IgH:Bcl2 were
cultured in IL-7 and the percent of cells in S phase was
assessed by BrdU incorporation. Shown is the mean and
standard deviation for two replicates. (B–C) Artemis/:
Pim2/:IgH:Bcl2 (B) and RAG1/:IgH:Bcl2 (C) pre–B cells
were transduced with an empty retroviral vector (empty)
or retrovirus expressing Pim2 (Pim2). Cells were cultured
in IL-7 and the percent of S-phase cells was assessed by
BrdU incorporation 3 d after retroviral transduction.
Shown is the mean and standard deviation of two replicates. Data in A, B, and C are representative of at least
three experiments. (D) Model illustrating context-dependent roles of Pim1 and Pim2 in developing pre–B cells.
Red lines represent inhibition and black arrows designate
activation. Pim1 and Akt activity are triggered by IL-7
receptor signals. These two kinases cooperate to support
pre–B cell survival through phosphorylation of BAD and
subsequent inactivation of BAX. Expression of Pim1 also
supports IL-7–driven proliferation. Loss of IL-7 leads to
loss of Pim1 and Akt activities, expression of RAG, and
initiation of IgL chain gene rearrangement. RAG DSBs
activate ATM, which induces Pim2 expression. Pim2 phosphorylates BAD and blocks pre–B cell proliferation.
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Notably, the expression of BAX, NOXA, and PUMA is not
altered by Pim2 deficiency (Fig. 3, H and I). Moreover, Pim2
does not modulate p53 phosphorylation (Fig. 3 J).
How then does Pim2 inhibit pre–B cell apoptosis? Like
PUMA and NOXA, the BAD protein promotes cell death by
binding to antiapoptotic proteins, such as Bcl-2 and Bcl-XL,
which would otherwise inhibit BAX activity (Youle and
Strasser, 2008). Phosphorylation of BAD triggers release of these
prosurvival factors (Youle and Strasser, 2008). In pre–B cells,
BAD is phosphorylated by Pim1 and Akt in response to IL-7
(unpublished data). In the absence of IL-7, up-regulation
of Pim2 by RAG DSBs maintains BAD phosphorylation
(Fig. 3 K). Thus, although RAG DSBs induce BAX expression, they also promote Pim2-dependent phosphorylation of
BAD, which will antagonize BAX proapoptotic activities.

pre–B cells (Fig. 4 D). To assemble IgL chain genes, pre–B cells
must attenuate IL-7 signals, including those that promote survival. Importantly, we show that RAG DSB-mediated signals
support pre–B cell survival, effectively replacing lost IL-7 prosurvival signals. However, if these DSBs persist unrepaired, they
would ultimately promote cell death. This temporal balance of
prosurvival and proapoptotic signaling would allow pre–B cells
the time needed to undergo multiple IgL chain gene rearrangements while, ultimately, eliminating any cells with persistent
unrepaired RAG DSBs. These activities, coupled with the cell
cycle checkpoint activity of Pim2, permit efficient IgL chain
gene assembly and prevent RAG DSBs from being aberrantly
resolved as chromosomal lesions, such as translocations, which
could lead to cellular transformation and cancer.

Pim2 enforces the G1-S checkpoint in pre–B cells
The Pim kinases have established roles in promoting proliferation downstream of cytokine receptors (Amaravadi and
Thompson, 2005; Nawijn et al., 2011). Consistent with this
function, Pim1 is required to promote proliferation downstream of the IL-7 receptor (unpublished data and Domen
et al., 1993). In stark contrast to the pro-proliferative activities
of Pim1, we find that Pim2 enforces the G1 to S checkpoint,
inhibiting the proliferation of pre–B cells with RAG DSBs.
In this regard, Artemis/:Pim2/:IgH:Bcl2 pre–B cell cultures have a higher percentage of S-phase cells than Artemis/:
IgH:Bcl2 pre–B cell cultures (Fig. 4 A). Indeed, the fraction
of S-phase Artemis/:Pim2/:IgH:Bcl2 pre–B cells is similar
to that of RAG1/:IgH:Bcl2 pre–B cells, which do not have
RAG DSBs and do not activate DSB-dependent checkpoint
pathways (Fig. 4 A). Expression of Pim2 in Artemis/:
Pim2/:IgH:Bcl2 pre–B cells leads to a decrease the percentage of S-phase cells (Fig. 4 B). However, expression of Pim2
in RAG1/:IgH:Bcl2 pre–B cells does not alter the percentage of S-phase RAG1/:IgH:Bcl2 pre–B cells (Fig. 4 C).
Together, these data demonstrate that RAG DSBs in pre–B
cells activate the G1-S checkpoint in a manner dependent on
Pim2 and that the antiproliferative properties of Pim2 are
unique to cells with DNA breaks.
The contrasting effects of Pim1 and Pim2 on cell proliferation are context dependent, permitting pre–B cell expansion in the presence of IL-7 (Pim1) but preventing proliferation
of pre–B cells that have initiated V(D)J recombination and
have RAG DSBs (Pim2). In the latter context, Pim2 promotes genomic stability by preventing cells with RAG DSBs
from entering S phase where these breaks could be aberrantly
repaired. Importantly, we show that the induction of Pim2
by RAG DSBs inhibits pre–B cells from entering S phase
even in the presence of IL-7. Thus, Pim2 would antagonize
proliferative signals from any residual IL-7 present when pre–
B cells have transited away from IL-7–producing stromal cells
(Tokoyoda et al., 2004; Johnson et al., 2008).
We have shown that distinct signaling pathways activated
by the IL-7 receptor and by RAG DSBs are functionally integrated to regulate the proliferation and survival of developing

Mice. All mice were bred and maintained under specific pathogen-free conditions at the Washington University School of Medicine and were handled in
accordance with the guidelines set forth by the Division of Comparative Medicine of Washington University. Wild-type B6 mice (The Jackson Laboratory)
were used as controls. All other mice are on a mixed genetic background.
Primary cell culture. Bone marrow was harvested from 4–6-wk-old mice
and cultured for 7–10 d at 2 × 106 cells/ml in media containing IL-7 at 5 ng/ml.
For IL-7 withdrawal experiments, cells were resuspended in media without IL-7
and maintained at 2 × 106 cells/ml. The ATM inhibitor KU-55933 (SigmaAldrich) was used at 15 µM. Akt inhibitor VIII (EMD) was used at 5 µM.
cDNA expression and shRNA mediated knockdown. cDNAs encoding Pim2 or Pim2-KD were cloned into the MSCV retrovirus containing an
IRES sequence followed by Thy1.1 cDNA as a marker of transduced cells.
For Pim2-KD, the lysine at residue 121 was changed to methionine by
PCR-based site-directed mutagenesis of Pim2 cDNA and confirmed by sequencing (Fox et al., 2003). shRNAs were cloned into the MSCV-hCD2mir30 vector as previously described (Amin and Schlissel, 2008). Targeted
sequences are as follows: Pim2, 5-GGGAGGTACTGCTCATTAA-3;
and p53, 5-CCCACTACAAGTACATGTGTAA-3. Retrovirus was produced in platE cells by transfection of the retroviral plasmid with Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol. Viral
supernatant was collected and pooled from 24–72 h after transfection. Viral
particles were concentrated by addition of PEG-8000 (Sigma-Aldrich; final
concentration 8%), incubation at 4°C overnight, and centrifugation at 2,500
RPM for 20 min. Precipitated virus was resuspended at 300× concentration
in sterile PBS. Cells (10 × 106/ml) were transduced with viral particles (final
6-10×) in standard media containing 5 µg/ml polybrene and centrifuged for
2 h at 1,100 RPM at room temperature. Cells were incubated overnight in
virus-containing media and then placed in fresh media at 2 × 106 cells/ml.
Cells expressing the retroviral construct were identified by flow cytometric
assessment of Thy1.1 or hCD2 expression using a FACSCalibur (BD).
Transduced cells were sorted using biotin-hCD2 or biotin-Thy1.1 (both
from BD) and anti-biotin magnetic beads (Miltenyi Biotec) on MS columns
(Miltenyi Biotec) according to the manufacturer’s protocol.
Flow cytometric analyses. All flow cytometric analyses were performed
on a FACSCalibur. Antibodies used included FITC-conjugated anti-CD45R/
B220 and allophycocyanin (APC)-conjugated anti-IgM, PE-conjugated
anti-CD43, APC-conjugated anti-hCD2, PE-conjugated anti-hCD2, and
PE-conjugated anti-Thy1.1. All antibodies were obtained from BD. Cell viability was assessed by incubation of cells for 10 min at room temperature
with 0.5 µg/ml of 7AAD (BD). Proliferation was assessed using the BrdUFITC kit (BD) per the manufacturer’s instructions.
Southern blot. Southern blot analyses of coding ends generated during
rearrangement at the IgL locus were performed on genomic DNA
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digested with SacI and EcoRI using the JIII probe as described previously
(Bredemeyer et al., 2008).
Western blot and EMSA analyses. Western blots were done on whole cell
lysates as previously described (Bredemeyer et al., 2008). Anti–phospho(Thr308)Akt, anti–total Akt, anti–phospho(Ser256)-Foxo1, anti–phospho(Ser15)-p53,
and anti–phospho(Ser112)-BAD antibodies were obtained from Cell Signaling
Technology. Anti-Pim1, anti-Pim2, and anti-Gapdh antibodies were obtained
from Santa Cruz Biotechnology, Inc. Secondary reagents were horseradish peroxidase–conjugated goat anti–mouse IgG (Invitrogen) or donkey anti–rabbit IgG
(GE Healthcare). Quantitation was done using ImageJ software (National Institutes of Health) and ratios of bands are all referenced to loading controls.

Statistical analysis. All p-values were generated via Student’s t test using
Prism (GraphPad Software).
Online supplemental material. Fig. S1 shows shows flow cytometric analysis of bone marrow from mice used to generate IL-7 cultures.
Online supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20112078/DC1.
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